The Relationship between the Behavioral Hearing Thresholds and Maximum Bilirubin Levels at Birth in Children with a History of Neonatal Hyperbilirubinemia
Original Article
Iranian Journal of Otorhinolaryngology No.3, Vol.25, Serial No.72, June 2013
The Relationship between the Behavioral Hearing Thresholds and
Maximum Bilirubin Levels at Birth in Children with a History of
Neonatal Hyperbilirubinemia
Rasool Panahi1,*Zahra Jafari2, Abdoreza Sheibanizade1, Masoud Salehi3,
Abdoreza Esteghamati4, Sara Hasani1
Abstract
Introduction:
Neonatal hyperbilirubinemia is one of the most important factors affecting the auditory system
and can cause sensorineural hearing loss. This study investigated the relationship between
behavioral hearing thresholds in children with a history of jaundice and the maximum level of
bilirubin concentration in the blood.
Materials and Methods:
This study was performed on 18 children with a mean age of 5.6 years and with a history of
neonatal hyperbilirubinemia. Behavioral hearing thresholds, transient evoked emissions and
brainstem evoked responses were evaluated in all children.
Results:
Six children (33.3%) had normal hearing thresholds and the remaining (66.7%) had some degree
of hearing loss. There was no significant relationship (r=-0.28, P=0.09) between the mean total
bilirubin levels and behavioral hearing thresholds in all samples. A transient evoked emission was
seen only in children with normal hearing thresholds however in eight cases brainstem evoked
responses had not detected.
Conclusion:
Increased blood levels of bilirubin at the neonatal period were potentially one of the causes of
hearing loss. There was a lack of a direct relationship between neonatal bilirubin levels and the
average hearing thresholds which emphasizes on the necessity of monitoring the various
amounts of bilirubin levels.
Keywords:
Behavioral, Hearing threshold, Hearing loss, Hyperbilirubinemia, Neonatal.
Received date: 29 Aug 2012
Accepted date: 28 Nov 2012
1
Department of Audiology, Faculty of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran.
Department of Basic Sciences in Rehabilitation, Faculty of Rehabilitation, Rehabilitation Research Center, Tehran
University of Medical Sciences, Tehran, Iran.
3
Department of Biostatistics, Faculty of Management and Medical Information, University of Medical Sciences, Tehran, Iran.
4
Children's Hospital, martyr Akbar-Abadi, Tehran University of Medical Sciences, Tehran, Iran.
*Corresponding Author:
Department of Basic Sciences in Rehabilitation, Faculty of Rehabilitation, Tehran University of Medical
Sciences, Nezam Alley, ShahidShahnazari St., Mother Sq., Mirdamad Blvd., Tehran, Iran.
Tel: +982122228051-2, Fax: +982122220946, E-mail: z_ .
2
127
Panahi R, et al
Introduction
High bilirubin level at birth has been
considered as one of the most important
factors affecting the auditory system.
Although this disease does not have
thoughtful consequences in most infants, in
the absence of appropriate treatment, high
levels of blood serum bilirubin can result in
acute encephalopathy and brain damage
(1,2). When red blood cells are broken
down, unconjugated bilirubin enters into the
plasma. Normally, this type of bilirubin
molecules link together by liver enzymes
and make conjugated bilirubin that the body
is able to excrete. However, if the bilirubin
does not convert to a conjugated mode, it
accumulates in plasma and its concentration
increases. With increasing levels of serum
bilirubin, the substance passes through the
blood brain barrier and enters the central
nervous system. Kernicterus is a
neurological syndrome that is due to
unconjugated bilirubin deposits in brain cells
and nuclei (3). Due to the involvement of
vestibular nerve, oculomotor nerve,
cerebellum and cerebral basal ganglia,
patients with kernicterus develop symptoms
such as movement disorders, impaired eye
movements and hearing loss. The only
clinical sign of kernicterus may be
permanent sensorineural hearing loss (4,5).
Jaundice in the first day following the birth
is always pathologic. Likewise, if the
maximum level of bilirubin in term neonate
exceeds beyond 13 mg/dL, it is considered
pathologic (6). Severe hyperbilirubinemia is
defined as serum bilirubin levels above 17
mg/dL (7). It seems that auditory brainstem
nuclei including the cochlear nuclei, inferior
colliculus and superior olivary complex are
the most vulnerable parts of the auditory
system against high bilirubin concentrations.
Damage to these structures can lead to
Sensor-Neural Hearing Loss (SNHL) (3,8).
Studies that reviewed audiological findings
in children with a history of neonatal
hyperbilirubinemia have primarily used
electrophysiological and non-behavioral tests
such as auditory brainstem response (ABR).
For instance, the study of Jiang et al on
infants with a history of neonatal hyperbilirubinemia revealed that the threshold of ABR
response recorded in these infants was
significantly increased (9). In the study of
Nickisch and colleagues in 2008 on two
groups of children with a history of neonatal
hyperbilirubinemia, it was reported that 87%
of children in the group with serum bilirubin
levels greater than 20 mg/dL and 13% of
children in the group with serum bilirubin
levels between 12-19 mg/dL suffered from
particular hearing impairment (10).
Evidence suggests that lower levels of
bilirubin may cause minor encephalopathy
that known as bilirubin- induced neurological
dysfunction (BIND). In this case, the hearing
impairment has been reported alone and
without any other signs of kernicterus (8).
The relationship between peak serum
bilirubin levels and behavioral hearing
thresholds has not well-defined yet
furthermore there is not enough evidence in
this field.
Considering the results of these studies and
assuming that different degrees of neonatal
hyperbilirubinemia can cause different
degrees of hearing impairment, our study
investigated the behavioral hearing thresholds
in children with a history of neonatal jaundice
and reported the frequency of hearing
impairment. This study also addressed the
relationship between the average hearing
thresholds and level of serum bilirubin.
Materials and Methods
This study was performed from January to
June 2012 at the audiology department of
faculty of rehabilitation in Tehran University
of Medical Sciences. Our study was
performed on 18 children aged 2.4 to 11
years (mean 5.6±2.5 years) and with a
history of neonatal hyperbilirubinemia. Of
these, 10 were girls (55.6%) and 8 (44.4%)
were boys. Additional information regarding
128 Iranian Journal of Otorhinolaryngology No.3, Vol.25, Serial No.72, June 2013
Relationship Between Maximum Bilirubin Level and Hearing Thresholds in Neonatal Hyperbilirubinemia
the children is summarized in Table 1.
Blood bilirubin levels at birth for each child
were determined according to the medical
record. In the inclusion criteria, a history of
phototherapy or exchange transfusion,
negative family history of hearing loss, no
history of respiratory distress, no history of
head trauma, epilepsy and ototoxic
medications and negative history of oth (...truncated)